Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
Clinical trial NCT04058756 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04058756
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2030-04-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.